WESTPORT, Conn., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (PRTG), a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as monotherapy and in ...
WESTPORT, Conn., June 26, 2023 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (PRTG), a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as single agents and in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results